Cubist Systematic Strategies, LLC F Star Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.18 - $6.39 $143 - $421	-66 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.77 - $5.36 $16,054 - $31,066	-5,796 Reduced 98.87%	66 $0
Q4 2021 Feb 14, 2022	BUY	$4.71 - $7.38 $27,610 - $43,261	5,862 New	5,862 $29,000
Q3 2021 Nov 15, 2021	SELL	$5.2 - $8.42 $6,078 - $9,842	-1,169 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$6.57 - $10.71 $7,680 - $12,519	1,169 New	1,169 $10,000

44.7K

Ticker FSTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,584,700
Description
F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company's principal product candidate is FS118 and is being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck c...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.